Annotation Detail

Information
Associated Genes
PBK
Associated Variants
PBK OVEREXPRESSION ( ENST00000301905.9 )
PBK OVEREXPRESSION ( ENST00000301905.9 )
Associated Disease
lung non-small cell carcinoma
Source Database
CIViC Evidence
Description
TOPK (PBK) silencing sensitized lung cancer cells to gefitinib in preclinical xenograft models. Over-expression was also associated with resistance in various lung cancer cell lines.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/835
Gene URL
https://civic.genome.wustl.edu/links/genes/13276
Variant URL
https://civic.genome.wustl.edu/links/variants/348
Rating
3
Evidence Type
Predictive
Disease
Lung Non-small Cell Carcinoma
Evidence Direction
Supports
Drug
Gefitinib
Evidence Level
D
Clinical Significance
Resistance
Pubmed
26745678
Drugs
Drug NameSensitivitySupported
GefitinibResitance or Non-Reponsetrue